$BLD

TAYLOR NANCY M sold (to issuer) 6,431 shares of BLD

TAYLOR NANCY M sold (to issuer) 6,431 shares of QXO Insulation, LLC (BLD) across 2 trades on 2026-07-01.

Original reporting
SEC EDGAR · TAYLOR NANCY M
Published Jul 1, 2026, 9:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BLD
Neutral
medium confidence
Mentioned
$BLD
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLDNeutralLow
01

Why it matters

A director-level sale to the issuer (code D) is disclosed, but without price/value, limiting actionable inference about fundamentals.

02

Market read

Primarily a trading-flow/governance datapoint; not a fundamental catalyst like earnings, guidance, or a deal.

03

What to watch

Because the price and total value are not disclosed, the economic magnitude is unclear; also, holdings after transaction are 0 shares, which may reflect plan mechanics rather than a directional view.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-01 (after-hours) for an insider sale dated 2026-07-01

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for QXO Insulation, LLC (BLD).

Company-level read

Ticker impact

$BLDNeutralMedium confidence
Context

SEC Form 4 shows director Nancy M. Taylor sold 6,431 shares of BLD to the issuer on 2026-07-01; price not disclosed.

Expected impact

Low near-term impact; treat as normal insider liquidity unless follow-on filings show sustained selling.

Evidence & confidence

The filing is a Form 4 insider transaction with sale-to-issuer code D, director role, and no price/value disclosed; such prints typically have modest standalone market impact.

Market effects

No sector-level read-through; this is company-specific insider transaction data only.

None indicated.

None indicated.

Counterpoint

If the sale-to-issuer reflects an ongoing repurchase program participation or accelerated liquidity need, it could be misread as bearish; the lack of disclosed price/value reduces interpretability.

Key entities

  • QXO Insulation, LLC

    Company named in the Form 4 insider transaction; ticker BLD.

  • Nancy M. Taylor

    Director who sold 6,431 shares to the issuer on 2026-07-01 (price not disclosed).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QXOMedAI 9/10

QXO Inc. (QXO) Launches Cash Tender Offers for TopBuild (BLD) Senior Notes Amid Pending Acquisition

QXO Inc. said it launched cash tender offers and consent solicitations to buy TopBuild Corp.’s outstanding 4.125% notes due 2032 and 5.625% notes due 2034 as part of its pending acquisition of TopBuild. QXO offered $961.25 per $1,000 principal, plus $50 for early tenders ($1,011.25 total), and sought indenture amendments to remove a change-of-control offer and most restrictive covenants.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.